An all-new study has come up with the revolutionary approach stating an experimental vaccine shot might help in preventing the overall risks of developing colon cancer in the long run. Around 1.2 million Americans tend to suffer from the condition referred to as “Lynch Syndrome.” It is a type of mutation that prevents the DNA of the individuals from repairing itself –increasing the overall risks of developing colorectal cancer by as much as 70-80 percent. A study conducted at Weill Cornell has revealed that an experimental vaccine shot improved the lifespan of mice by around 60 percent –in some cases, even preventing the risk of developing colon cancer.
The Study at Weill Cornell
Lynch Syndrome is referred to as the genetic condition affecting millions of Americans out there. The condition tends to enhance the chances of developing colon cancer in comparison to the rest of the population. Patients having Lynch Syndrome are also subject to being highly vulnerable to conditions like gastrointestinal cancers. Women with Lynch Syndrome are at a higher risk of developing ovarian and uterine cancers.
A team of researchers at Weill Cornell Medicine has come up with a vaccination that can help in destroying the mutated cells in mice DNA. The mice samples that the researchers had vaccinated were also given a standard anti-inflammatory drug. It was observed that the specific mice samples lived 60 percent more in comparison to the unvaccinated mice. The results of the study suggest that if a similar vaccine shot is developed for humans as well, it can help in protecting humans from lethal cancers.
Vaccine Shot Preventing Cancer Risks
Dr. Steven Lipkin –geneticist and a leading study author at Weill Cornell, stated, “Naproxen appears to work well for the mice samples in comparison to Aspirin. When combined, the vaccine shots worked the best towards preventing the risks of developing colorectal cancer.”
Also Read:6 Foods that Help Prevent Cancer
The researchers believe that such a vaccine shot for humans can help in curing the Lynch Syndrome patients as well over time. When started preventatively, the patients with Lynch Syndrome can also possibly live well just like those without the condition. While the study has been successful in mice samples, the scientists are looking forward to implementing the same in humans as well.